UBS OCONNOR LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$1,074,229
-31.1%
342,111
+13.2%
0.03%
-44.9%
Q2 2023$1,558,893
-18.6%
302,111
-16.8%
0.05%
-16.9%
Q1 2023$1,914,517
-99.8%
363,286
+62.9%
0.06%
+227.8%
Q3 2022$926,000,000
-55.1%
223,066
-56.5%
0.02%
-40.0%
Q2 2022$2,062,000,000512,8860.03%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q1 2022
NameSharesValueWeighting ↓
SUMMER ROAD LLC 6,122,089$31,590100.00%
Opaleye Management Inc. 5,780,000$29,824,8007.13%
DELTEC ASSET MANAGEMENT LLC 1,974,797$10,189,9532.23%
Lynwood Capital Management Inc. 262,500$1,354,5001.72%
Endurant Capital Management LP 368,438$1,901,1401.66%
Knoll Capital Management, LLC 200,000$1,032,0001.25%
Knoll Capital Management, LLC 95,800$814,3000.99%
SECTORAL ASSET MANAGEMENT INC 802,680$4,141,8290.69%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,977$1,553,0410.22%
Cormorant Asset Management, LP 645,000$3,328,2000.19%
View complete list of OCULAR THERAPEUTIX INC shareholders